Regulating the levels of key factors in cell cycle and DNA repair: New pathways revealed by lamins

Cell Cycle

Volumn 10, Issue 21, 2011, Pages 3652-3657

  Redwood, Abena B ^a   Gonzalez Suarez, Ignacio ^a   Gonzalo, Susana ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

A type lamins; Cell cycle; DNA repair; Proteases; Vitamin D

Indexed keywords

53BP1 PROTEIN; BRCA1 PROTEIN; CALCITRIOL; CATHEPSIN L; COLECALCIFEROL; HISTONE H2AX; HISTONE H3; LAMIN A; LAMIN C; OXYGENASE; PROTEIN P53; RAD51 PROTEIN; RETINOID X RECEPTOR; UNCLASSIFIED DRUG; VITAMIN D;

ANEUPLOIDY; CANCER SUSCEPTIBILITY; CELL CYCLE; CELL CYCLE REGULATION; CHROMATIN; CHROMOSOME ABERRATION; DNA REPAIR; DNA REPLICATION; DNA TRANSCRIPTION; DOUBLE STRANDED DNA BREAK; GENE CONTROL; GENOMIC INSTABILITY; HOMOLOGOUS RECOMBINATION; HUMAN; NONHUMAN; NUCLEAR LAMINA; PROTEIN DEGRADATION; REVIEW; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE;

EID: 80655140622     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.10.21.18201     Document Type: Review

References (51)

1. Broers JL, Ramaekers FC, Bonne G, Yaou RB, Hutchison CJ. Nuclear lamins: laminopathies and their role in premature ageing. Physiol Rev 2006; 86:967-1008; PMID:16816143; DOI:10.1152/phys-rev. 00047.2005.
2. Prokocimer M, Davidovich M, Nissim-Rafinia M, Wiesel-Motiuk N, Bar D, Barkan R, et al. Nuclear lamins: key regulators of nuclear structure and activities. Journal of cellular and molecular medicine 2009.
3. De Sandre-Giovannoli A, Bernard R, Cau P, Navarro C, Amiel J, Boccaccio I, et al. Lamin a truncation in Hutchinson-Gilford progeria. Science 2003; 300:2055; PMID:12702809; DOI:10.1126/science. 1084125.
4. Eriksson M, Brown WT, Gordon LB, Glynn MW, Singer J, Scott L, et al. Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome. Nature 2003; 423:293-8; PMID:12714972; DOI:10.1038/nature01629.
5. Goldman RD, Shumaker DK, Erdos MR, Eriksson M, Goldman AE, Gordon LB, et al. Accumulation of mutant lamin A causes progressive changes in nuclear architecture in Hutchinson-Gilford progeria syndrome. Proc Natl Acad Sci USA 2004; 101:8963-8; PMID:15184648; DOI:10.1073/pnas.0402943101.
6. Liu B, Wang J, Chan KM, Tjia WM, Deng W, Guan X, et al. Genomic instability in laminopathy-based premature aging. Nat Med 2005; 11:780-5; PMID:15980864; DOI:10.1038/nm1266.
7. Scaffidi P, Misteli T. Lamin A-dependent nuclear defects in human aging. Science 2006; 312:1059-63; PMID:16645051; DOI:10.1126/science.1127168.
8. Lombard DB, Chua KF, Mostoslavsky R, Franco S, Gostissa M, Alt FW. DNA repair, genome stability and aging. Cell 2005; 120:497-512; PMID:15734682; DOI:10.1016/j.cell.2005.01.028.
9. Musich PR, Zou Y. Genomic instability and DNA damage responses in progeria arising from defective maturation of prelamin A. Aging (Albany NY) 2009; 1:28-37; PMID:19851476.
10. Liu Y, Wang Y, Rusinol AE, Sinensky MS, Liu J, Shell SM, et al. Involvement of xeroderma pigmentosum group A (XPA) in progeria arising from defective maturation of prelamin A. FASEB J 2008; 22:603-11; PMID:17848622; DOI:10.1096/fj.07-8598com.
11. Liu GH, Barkho BZ, Ruiz S, Diep D, Qu J, Yang SL, et al. Recapitulation of premature ageing with iPSCs from Hutchinson-Gilford progeria syndrome. Nature 2011; 472:221-5; PMID:21346760; DOI:10.1038/ nature09879.
12. Hartlerode AJ, Scully R. Mechanisms of double-strand break repair in somatic mammalian cells. Biochem J 2009; 423:157-68; PMID:19772495; DOI:10.1042/BJ20090942.
13. Jackson SP, Bartek J. The DNA-damage response in human biology and disease. Nature 2009; 461:1071-8; PMID:19847258; DOI:10.1038/nature08467.
14. Mao Z, Bozzella M, Seluanov A, Gorbunova V. Comparison of nonhomologous end joining and homologous recombination in human cells. DNA Repair (Amst) 2008; 7:1765-71; PMID:18675941; DOI:10.1016/j.dnarep.2008.06.018.
15. 2 phase. EMBO J 2011; 30:1079-92; PMID:21317870; DOI:10.1038/emboj. 2011.27.
16. Iliakis G, Wang H, Perrault AR, Boecker W, Rosidi B, Windhofer F, et al. Mechanisms of DNA double strand break repair and chromosome aberration formation. Cytogenet Genome Res 2004; 104:14-20; PMID:15162010; DOI:10.1159/000077461.
17. Wang M, Wu W, Wu W, Rosidi B, Zhang L, Wang H, et al. PARP-1 and Ku compete for repair of DNA double strand breaks by distinct NHEJ pathways. Nucleic Acids Res 2006; 34:6170-82; PMID:17088286; DOI:10.1093/nar/gkl840.
18. Gonzalez-Suarez I, Redwood AB, Perkins SM, Vermolen B, Lichtensztejin D, Grotsky DA, et al. Novel roles for A-type lamins in telomere biology and the DNA damage response pathway. EMBO J 2009; 28:2414-27; PMID:19629036; DOI:10.1038/emboj.2009.196.
19. Redwood AB, Perkins SM, Vanderwaal RP, Feng Z, Biehl KJ, Gonzalez-Suarez I, et al. A dual role for A-type lamins in DNA double-strand breaks repair. Cell Cycle 2011; 10:2549-60; PMID:21701264; DOI:10.4161/cc.10.15.16531.
20. Gonzalez-Suarez I, Gonzalo S. Crosstalk between chromatin structure, nuclear compartmentalization and telomere biology. Cytogenet Genome Res 2008; 122:202-10; PMID:19188688; DOI:10.1159/000167805.
21. Gonzalez-Suarez I, Redwood AB, Gonzalo S. Loss of A-type lamins and genomic instability. Cell Cycle 2009; 8:3860-5; PMID:19901537; DOI:10.4161/cc.8.23.10092.
22. Difilippantonio S, Gapud E, Wong N, Huang CY, Mahowald G, Chen HT, et al. 53BP1 facilitates long-range DNA end-joining during V(D)J recombination. Nature 2008; 456:529-33; PMID:18931658; DOI:10.1038/nature07476.
23. Manis JP, Morales JC, Xia Z, Kutok JL, Alt FW, Carpenter PB. 53BP1 links DNA damage-response pathways to immunoglobulin heavy chain class-switch recombination. Nat Immunol 2004; 5:481-7; PMID:15077110; DOI:10.1038/ni1067.
24. Ward IM, Reina-San-Martin B, Olaru A, Minn K, Tamada K, Lau JS, et al. 53BP1 is required for class switch recombination. J Cell Biol 2004; 165:459-64; PMID:15159415; DOI:10.1083/jcb.200403021.
25. Dimitrova N, Chen YC, Spector DL, de Lange T. 53BP1 promotes nonhomologous end joining of telomeres by increasing chromatin mobility. Nature 2008; 456:524-8; PMID:18931659; DOI:10.1038/nature07433.
26. Bothmer A, Robbiani DF, Feldhahn N, Gazumyan A, Nussenzweig A, Nussenzweig MC. 53BP1 regulates DNA resection and the choice between classical and alternative end joining during class switch recombination. J Exp Med 2010; 207:855-65; PMID:20368578; DOI:10.1084/jem.20100244.
27. Bunting SF, Callen E, Wong N, Chen HT, Polato F, Gunn A, et al. 53BP1 inhibits homologous recombination in Brca1-deficient cells by blocking resection of DNA breaks. Cell 2010; 141:243-54; PMID:20362325; DOI:10.1016/j.cell.2010. 03.012.
28. Nakamura K, Sakai W, Kawamoto T, Bree RT, Lowndes NF, Takeda S, et al. Genetic dissection of vertebrate 53BP1: a major role in nonhomologous end joining of DNA double strand breaks. DNA Repair (Amst) 2006; 5:741-9; PMID:16644291; DOI:10.1016/j.dnarep.2006.03.008.
29. Morales JC, Xia Z, Lu T, Aldrich MB, Wang B, Rosales C, et al. Role for the BRCA1 C-terminal repeats (BRCT) protein 53BP1 in maintaining genomic stability. J Biol Chem 2003; 278:14971-7; PMID:12578828; DOI:10.1074/jbc. M212484200.
30. Ward IM, Minn K, van Deursen J, Chen J. p53 Binding protein 53BP1 is required for DNA damage responses and tumor suppression in mice. Mol Cell Biol 2003; 23:2556-63; PMID:12640136; DOI:10.1128/MCB.23.7.2556-63.2003.
31. Wang B, Matsuoka S, Carpenter PB, Elledge SJ. 53BP1, a mediator of the DNA damage checkpoint. Science 2002; 298:1435-8; PMID:12364621; DOI:10.1126/science.1076182.
32. Gonzalez-Suarez I, Redwood AB, Grotsky DE, Neumann M, Cheng E, Stewart CL, et al. A new pathway regulating 53BP1 stability implicates Cathepsin L and vitamin D in DNA repair. EMBO J 2011; In press; PMID:21750527; DOI:10.1038/emboj.2011.225.
33. Katunuma N. Mechanisms and regulation of lysosomal proteolysis. Revis Biol Celular 1989; 20:35-61; PMID:2700097.
34. Reiser J, Adair B, Reinheckel T. Specialized roles for cysteine cathepsins in health and disease. J Clin Invest 2010; 120:3421-31; PMID:20921628; DOI:10.1172/JCI42918.
35. Gocheva V, Joyce JA. Cysteine cathepsins and the cutting edge of cancer invasion. Cell Cycle 2007; 6:60-4; PMID:17245112; DOI:10.4161/cc.6.1.3669.
36. Jedeszko C, Sloane BF. Cysteine cathepsins in human cancer. Biol Chem 2004; 385:1017-27; PMID:15576321; DOI:10.1515/BC.2004.132.
37. Miyamoto K, Iwadate M, Yanagisawa Y, Ito E, Imai J, Yamamoto M, et al. Cathepsin L is highly expressed in gastrointestinal stromal tumors. Int J Oncol 2011; 39:1109-15; PMID:21769426.
38. Duncan EM, Muratore-Schroeder TL, Cook RG, Garcia BA, Shabanowitz J, Hunt DF, et al. Cathepsin L proteolytically processes histone H3 during mouse embryonic stem cell differentiation. Cell 2008; 135:284-94; PMID:18957203; DOI:10.1016/j. cell.2008.09.055.
39. Goulet B, Baruch A, Moon NS, Poirier M, Sansregret LL, Erickson A, et al. A cathepsin L isoform that is devoid of a signal peptide localizes to the nucleus in S phase and processes the CDP/Cux transcription factor. Mol Cell 2004; 14:207-19; PMID:15099520; DOI:10.1016/S1097-2765(04)00209-6.
40. Varela I, Cadinanos J, Pendas AM, Gutierrez-Fernandez A, Folgueras AR, Sanchez LM, et al. Accelerated ageing in mice deficient in Zmpste24 protease is linked to p53 signalling activation. Nature 2005; 437:564-8; PMID:16079796; DOI:10.1038/nature04019.
41. Bouwman P, Aly A, Escandell JM, Pieterse M, Bartkova J, van der Gulden H, et al. 53BP1 loss rescues BRCA1 deficiency and is associated with triplenegative and BRCA-mutated breast cancers. Nat Struct Mol Biol 2010; 17:688-95; PMID:20453858; DOI:10.1038/nsmb.1831.
42. Bindra RS, Glazer PM. Repression of RAD51 gene expression by E2F4/p130 complexes in hypoxia. Oncogene 2007; 26:2048-57; PMID:17001309; DOI:10.1038/sj.onc.1210001.
43. Hegan DC, Lu Y, Stachelek GC, Crosby ME, Bindra RS, Glazer PM. Inhibition of poly(ADP-ribose) polymerase downregulates BRCA1 and RAD51 in a pathway mediated by E2F4 and p130. Proc Natl Acad Sci USA 2010; 107:2201-6; PMID:20133863; DOI:10.1073/pnas.0904783107.
44. Johnson BR, Nitta RT, Frock RL, Mounkes L, Barbie DA, Stewart CL, et al. A-type lamins regulate retinoblastoma protein function by promoting subnuclear localization and preventing proteasomal degradation. Proc Natl Acad Sci USA 2004; 101:9677-82; PMID:15210943; DOI:10.1073/pnas.0403250101.
45. Nitta RT, Jameson SA, Kudlow BA, Conlan LA, Kennedy BK. Stabilization of the retinoblastoma protein by A-type nuclear lamins is required for INK4A-mediated cell cycle arrest. Mol Cell Biol 2006; 26:5360-72; PMID:16809772; DOI:10.1128/MCB.02464-05.
46. Nitta RT, Smith CL, Kennedy BK. Evidence that proteasome-dependent degradation of the retinoblastoma protein in cells lacking A-type lamins occurs independently of gankyrin and MDM2. PLoS ONE 2007; 2:963; PMID:17896003; DOI:10.1371/Journal. pone.0000963.
47. Demay MB. Mechanism of vitamin D receptor action. Ann NY Acad Sci 2006; 1068:204-13; PMID:16831920; DOI:10.1196/annals.1346.026.
48. Plum LA, DeLuca HF. Vitamin D, disease and therapeutic opportunities. Nat Rev Drug Discov 2010; 9:941-55; PMID:21119732; DOI:10.1038/nrd3318.
49. Alvarez-Díaz S, Valle N, Garcia JM, Pena C, Freije JM, Quesada V, et al. Cystatin D is a candidate tumor suppressor gene induced by vitamin D in human colon cancer cells. J Clin Invest 2009; 119:2343-58; PMID:19662683; DOI:10.1172/JCI37205.
50. Lin R, Nagai Y, Sladek R, Bastien Y, Ho J, Petrecca K, et al. Expression profiling in squamous carcinoma cells reveals pleiotropic effects of vitamin D3 analog EB1089 signaling on cell proliferation, differentiation and immune system regulation. Molecular endocrinology (Baltimore, MD) 2002; 16:1243-56. (Pubitemid 34621073)
51. Swami S, Raghavachari N, Muller UR, Bao YP, Feldman D. Vitamin D growth inhibition of breast cancer cells: gene expression patterns assessed by cDNA microarray. Breast Cancer Res Treat 2003; 80:49-62; PMID:12889598; DOI:10.1023/A:1024487118457.